Timmune Biotech Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Hematological Malignancy With Novel CAR-T Cells. (NCT04191941) | Timmune Biotech Inc. | 2019-09-01 |
| Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy (NCT03910842) | Timmune Biotech Inc. | 2019-03-21 |
| Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy (NCT03790891) | Timmune Biotech Inc. | 2019-01-05 |
| Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With CD19-TriCART Cell Therapy (NCT03720496) | Timmune Biotech Inc. | 2018-11-01 |
| Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy (NCT03649529) | Timmune Biotech Inc. | 2018-09-27 |
| Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19 (NCT03497533) | Timmune Biotech Inc. | 2018-08-03 |
Track Timmune Biotech Inc. automatically
Every clearance here is in the API, with alerts when new ones post.